News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

AI Thinks Like Us – Flaws and All: New Study Finds ChatGPT Mirrors Human Decision Biases in Half the Tests
News Release

BALTIMORE, MD, April 1, 2025 – Can we really trust AI to make better decisions than humans? A new study says … not always. Researchers have discovered that OpenAI’s ChatGPT, one of the most advanced and popular AI models, makes the same kinds of decision-making mistakes as humans in some situations showing biases like overconfidence of hot-hand (gambler’s) fallacy yet acting inhuman in others (e.g., not suffering from base-rate neglect or sunk cost fallacies).

Read More
In 2025, you can’t have an effective democracy without data literacy
Media Coverage

You are swimming in an ocean of data and don’t even realize it. All around you are invisible amounts of data that would be staggering to try to comprehend. Thousands of smartphones and smart devices are talking to, sending and downloading vast amounts of data, video, audio, words, numbers, images, you name it. Everything from the latest movie on Netflix to someone’s radiology results from a cancer screening.

Read More
Shell Shocked: How Small Eateries Are Dealing With Record Egg Prices
Media Coverage

Mom-and-pop businesses are trying to adapt to the soaring cost of eggs. The owners of four egg-centric restaurants across the country show how they are coping with this threat to their livelihoods.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
How do mRNA vaccines work - and why do you need a second dose? 5 essential reads

How do mRNA vaccines work - and why do you need a second dose? 5 essential reads

The Telegraph, March 16, 2021

Tens of millions of people across the U.S. have received a coronavirus vaccine. So far, the majority of doses have been either the Moderna or Pfizer vaccine, both of which use mRNA to generate an immune response. These gene-based vaccines have been in the works for decades, but this is the first time they have been used widely in people.

Coronavirus Today: The great reopening

Coronavirus Today: The great reopening

Los Angeles Times, March 15, 2021

Good evening. I’m Deborah Netburn, a science and features writer at the Los Angeles Times, filling in for Thuc Nhi Nguyen for a few days. You may remember me from my previous stints with the newsletter — it’s nice to be back! It’s Monday, March 15, and here’s what’s happening with the coronavirus in California and beyond.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine